This inventor holds 1 USPTO granted patent. Top assignee: Denali Therapeutics Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovations of Adam Catherman
Introduction
Adam Catherman is an accomplished inventor based in South San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of protein formulations. His work is instrumental in advancing therapeutic solutions for various medical conditions.
Latest Patents
Adam Catherman holds a patent for "Formulations of Protein Molecules Comprising Iduronate 2-Sulfatase." This innovative formulation is crucial for enhancing the efficacy of treatments related to specific enzyme deficiencies. His patent portfolio includes 1 patent, showcasing his focused expertise in this specialized area.
Career Highlights
Catherman is currently employed at Denali Therapeutics Inc., a company dedicated to developing therapies for neurodegenerative diseases. His role at Denali Therapeutics allows him to apply his knowledge and skills in a collaborative environment, contributing to groundbreaking research and development.
Collaborations
Throughout his career, Adam has worked alongside talented professionals, including Tina Giese and Dana Andersen. These collaborations have fostered a dynamic exchange of ideas and innovations, further enhancing the impact of their collective work.
Conclusion
Adam Catherman's contributions to the field of biotechnology exemplify the importance of innovation in developing effective medical therapies. His patent and work at Denali Therapeutics Inc. highlight his commitment to advancing healthcare solutions.